|
|
|
Press Releases
All Releases
 |
Harvard Bioscience, Inc. Acquires Coulbourn Instruments -- a Leading Manufacturer of Systems Used in the Behavioral Research Market
Aug 23, 2010
|
13.5 KB |
|
| |
HOLLISTON, Mass., Aug. 23, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it has acquired the business of Coulbourn Instruments through a purchase of substantially all of Coulbo...
|
|
HBIO Reports Second Quarter 2010 Revenue Growth of 44% Over Second Quarter 2009
Aug 5, 2010
|
45.5 KB |
|
| |
HOLLISTON, Mass., Aug. 5, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited financial highlights for the three and six months ended June 30, 2010.Second Quarter Reported Result...
|
|
Harvard Bioscience, Inc. Schedules Second Quarter 2010 Conference Call for August 5, 2010
Jul 26, 2010
|
12.0 KB |
|
| |
HOLLISTON, Mass., July 26, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, will announce results for the three and six months ended June 30, 2010 before market trading hours on Thu...
|
|
Harvard Bioscience Novel Bioreactor Helps Grow First Functional Lung for Successful Transplant in Collaboration With Dr. Harald Ott and Massachusetts General Hospital
Jul 20, 2010
|
13.6 KB |
|
| |
HOLLISTON, Mass., July 20, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, announces that its Harvard Apparatus / Hugo Sachs Elektronik business collaborated with Dr. Harald Ott an...
|
|
HBIO President David Green to Present at the Jefferies 2010 Global Life Sciences Conference
Jun 4, 2010
|
10.9 KB |
|
| |
HOLLISTON, Mass., June 4, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, today announced that its President, David Green, will present at the Jefferies 2010 Life Sciences Conferen...
|
|
HBIO Reports First Quarter 2010 Revenue Growth of 38% Over First Quarter 2009
Apr 29, 2010
|
39.5 KB |
|
| |
HOLLISTON, Mass., April 29, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited financial highlights for the first quarter ended March 31, 2010.First Quarter Reported Results
R...
|
|
Harvard Bioscience, Inc. Schedules First Quarter 2010 Conference Call for April 29, 2010
Apr 21, 2010
|
11.4 KB |
|
| |
HOLLISTON, Mass., April 21, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, will announce results for the first quarter ended March 31, 2010 before market trading hours on Thursday...
|
|
Photo Release -- Harvard Bioscience, Inc. Launches Its First Regenerative Medicine Product
Mar 9, 2010
|
15.3 KB |
|
| |
HOLLISTON, Mass., March 9, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research, today announced the launch of its ORGANIZER™ Series Model 100 "In Breath" bioreactor. This bioreactor was used to grow the bronchus...
|
|
Harvard Bioscience Engages The Investor Relations Group
Mar 4, 2010
|
13.4 KB |
|
| |
HOLLISTON, Mass., March 4, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience (Nasdaq:HBIO) has engaged The Investor Relations Group to increase awareness of Harvard Bioscience's long track record of growth and profitability.
David Green, President of HBIO, commented, "As we recently announced, for 2009 we achieved near record non-GAAP EPS in the worst...
|
|
Harvard Bioscience President David Green to Present at Cowen and Company 30th Annual Health Care Conference on March 9, 2010
Mar 1, 2010
|
10.4 KB |
|
| |
HOLLISTON, Mass., March 1, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research, today announced that its President, David Green, will present at the Cowen and Company 30th Annual Health Care Conference on Tuesda...
|
|
HBIO Reports 20% Revenue Growth for Fourth Quarter 2009
Feb 25, 2010
|
51.0 KB |
|
| |
HOLLISTON, Mass., Feb. 25, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, today reported unaudited financial highlights for the fourth quarter and full year ended December 31, 2009.Fourth Quarter Reported Results
Revenues ...
|
|
Harvard Bioscience, Inc. Schedules Fourth Quarter 2009 Conference Call for February 25, 2010
Feb 18, 2010
|
13.9 KB |
|
| |
HOLLISTON, Mass., Feb. 18, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research, will announce results for the four...
|
|
HBIO President David Green to Present January 19, 2010 at Global Investor Day 2010
Jan 12, 2010
|
10.4 KB |
|
| |
HOLLISTON, Mass., Jan. 12, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research, today announced that its President, David Green, will present on January 19, 2010 from 9:00 a.m. - 9:30 a.m. EST at Global Investor ...
|
|
HBIO Reports Third Quarter 2009 Revenue Growth of 5% Over Third Quarter 2008
Nov 4, 2009
|
36.4 KB |
|
| |
HOLLISTON, Mass., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, today reported unaudited financial highlights for the three and nine months ended September 30, 2009.
Third Quarter Reported Results
Revenues fro...
|
|
Harvard Bioscience, Inc. Schedules Third Quarter 2009 Conference Call for November 4, 2009
Oct 23, 2009
|
10.6 KB |
|
| |
HOLLISTON, Mass., Oct. 23, 2009 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research, will announce results for the third quarter ended September 30, 2009 after market trading hours on Wednesday, November 4, 2009.
A...
|
|
HBIO President David Green to Present At 2009 UBS Global Life Sciences Conference On September 23, 2009
Sep 10, 2009
|
8.3 KB |
|
| |
HOLLISTON, Mass., Sept. 10, 2009 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research, today announced that its President, David Green, will present at the 2009 UBS Global Life Sciences Conference on Wednesday, Septemb...
|
|
HBIO Acquires Denville Scientific, Inc. -- A Well Established Supplier of Consumables for the Molecular Biology Market
Sep 3, 2009
|
13.1 KB |
|
| |
HOLLISTON, Mass., Sept. 3, 2009 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, today announced that it has acquired the business of Denville Scientific, Inc. through a purchase of substantially all of Denville's assets and the ass...
|
|
HBIO Reports Second Quarter 2009 Results
Aug 6, 2009
|
39.5 KB |
|
| |
HOLLISTON, Mass., Aug. 6, 2009 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, today reported unaudited financial highlights for the three and six months ended ...
|
|
Harvard Bioscience, Inc. Schedules Second Quarter 2009 Conference Call for August 6, 2009
Jul 21, 2009
|
9.6 KB |
|
| |
HOLLISTON, Mass., Jul 21, 2009 (GlobeNewswire via COMTEX) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research, will announce results for the second quarter ended June 30, 2009 after market trading hours on Thursday, August 6, 2009....
|
|
Harvard Bioscience, Inc. Joins Russell 2000 Index
Jul 21, 2009
|
11.4 KB |
|
| |
HOLLISTON, Mass., July 21, 2009 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research, today announced that on June 26, 2009 it was added t...
|
|
|
=add release to Briefcase Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.
|
|
|
